Open Access1ISG-016 Evaluation of substitution and switch to etanercept biosimilar and related cost savings
Author(s) -
I Moya-Carmona,
C Estaún-Martínez,
M Pedrosa-Ruiz,
L Dani-Ben,
JM Fernández-Ovies
Publication year - 2018
Publication title -
pubmed central
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1136/ejhpharm-2018-eahpconf.16
Subject(s) - etanercept , biosimilar , medicine , medical prescription , pharmacy , rheumatology , clinical endpoint , maintenance therapy , intensive care medicine , pharmacology , family medicine , tumor necrosis factor alpha , clinical trial , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom